{"id":"https://openalex.org/W4297947463","doi":"https://doi.org/10.17615/50yt-m563","title":"A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges","display_name":"A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges","publication_year":2020,"publication_date":"2020-04-18","ids":{"openalex":"https://openalex.org/W4297947463","doi":"https://doi.org/10.17615/50yt-m563"},"language":"en","primary_location":{"id":"pmh:cdr.lib.unc.edu:5t34sq638","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/50yt-m563","pdf_url":"https://doi.org/10.17615/50yt-m563","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Antimicrobial Chemotherapy, 71(6)","raw_type":"Article"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.17615/50yt-m563","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Victor Garcia,","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor Garcia,","raw_affiliation_strings":["University of North Carolina at Chapel Hill","School of Medicine, Division of Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"School of Medicine, Division of Infectious Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020128969","display_name":"Rae Ann Spagnuolo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spagnuolo, Rae Ann","raw_affiliation_strings":["University of North Carolina at Chapel Hill","School of Medicine, Division of Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"School of Medicine, Division of Infectious Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066006619","display_name":"Justin Steve","orcid":"https://orcid.org/0000-0002-1554-986X","observed_orcids":["https://orcid.org/0000-0002-1554-986X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve, Justin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060742318","display_name":"Bonnie J. Howell","orcid":"https://orcid.org/0000-0002-5915-9943","observed_orcids":["https://orcid.org/0000-0002-5915-9943"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howell, Bonnie J.","raw_affiliation_strings":["School of Medicine, Division of Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Division of Infectious Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114031373","display_name":"Caroline Baker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Baker, Caroline E.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088571596","display_name":"Daria J. Hazuda","orcid":"https://orcid.org/0000-0002-6894-1056","observed_orcids":["https://orcid.org/0000-0002-6894-1056"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hazuda, Daria J.","raw_affiliation_strings":["School of Medicine, Division of Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Division of Infectious Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045677417","display_name":"Martina Kov\u00e1\u0159ov\u00e1","orcid":"https://orcid.org/0000-0001-7152-1709","observed_orcids":["https://orcid.org/0000-0001-7152-1709"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kovarova, Martina","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113547593","display_name":"Michael D. Swanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swanson, Michael D.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109398557","display_name":"Rosa I. S\u00e1nchez","orcid":"https://orcid.org/0000-0002-5348-2432","observed_orcids":["https://orcid.org/0000-0002-5348-2432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanchez, Rosa I.","raw_affiliation_strings":["School of Medicine, Division of Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Division of Infectious Diseases","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31508479,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.5288000106811523,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.5288000106811523,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.3422999978065491,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.11800000071525574,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.996999979019165},{"id":"https://openalex.org/keywords/long-acting-injectable-antiretrovirals","display_name":"long-acting injectable antiretrovirals","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hiv-pre-exposure-prophylaxis","display_name":"HIV pre-exposure prophylaxis","score":0.921999990940094},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.8100000023841858},{"id":"https://openalex.org/keywords/antiretroviral-therapy-adherence","display_name":"antiretroviral therapy adherence","score":0.7149999737739563},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.9629862308502197},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.7243160605430603},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6175506711006165},{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.6000047922134399},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.5847980976104736},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5517513155937195},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5025455951690674},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4840197265148163},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2111884355545044},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.18698346614837646},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1743432879447937},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:cdr.lib.unc.edu:5t34sq638","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/50yt-m563","pdf_url":"https://doi.org/10.17615/50yt-m563","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Antimicrobial Chemotherapy, 71(6)","raw_type":"Article"},{"id":"doi:10.17615/50yt-m563","doi":"https://doi.org/10.17615/50yt-m563","is_oa":true,"landing_page_url":"https://doi.org/10.17615/50yt-m563","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:cdr.lib.unc.edu:5t34sq638","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/50yt-m563","pdf_url":"https://doi.org/10.17615/50yt-m563","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Antimicrobial Chemotherapy, 71(6)","raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1124570276","display_name":"Next Generation Pre-exposure Prophylaxis","funder_award_id":"R01AI096138","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G1955480035","display_name":"Prevention of HIV Acquisition by Long-acting Antiretroviral PrEP","funder_award_id":"R01AI073146","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2230551448","display_name":null,"funder_award_id":"P30 AI-50410","funder_id":"https://openalex.org/F4320332582","funder_display_name":"Center for AIDS Research, University of Washington"},{"id":"https://openalex.org/G9000894295","display_name":"The University of North Carolina Center for AIDS Research","funder_award_id":"P30AI050410","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332582","display_name":"Center for AIDS Research, University of Washington","ror":"https://ror.org/00cvxb145"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4297947463.pdf","grobid_xml":"https://content.openalex.org/works/W4297947463.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2808654075","https://openalex.org/W3002644973","https://openalex.org/W2266101358","https://openalex.org/W2418956875","https://openalex.org/W4312872969","https://openalex.org/W602198522","https://openalex.org/W4288063375","https://openalex.org/W2143055379","https://openalex.org/W3083258381","https://openalex.org/W4283641778"],"abstract_inverted_index":{"Pre-exposure":[0],"prophylaxis":[1],"(PrEP)":[2],"using":[3],"antiretroviral":[4],"drugs":[5],"(ARVs)":[6],"has":[7],"been":[8],"shown":[9],"to":[10,23,49],"reduce":[11],"HIV":[12,20,31,66],"transmission":[13],"in":[14],"people":[15],"at":[16],"high":[17],"risk":[18],"of":[19,30,60,64],"infection.":[21],"Adherence":[22],"PrEP":[24],"strongly":[25],"correlates":[26],"with":[27],"the":[28],"level":[29],"protection.":[32],"Long-acting":[33],"injectable":[34],"ARVs":[35],"provide":[36],"sustained":[37],"systemic":[38],"drug":[39],"exposures":[40],"over":[41],"many":[42],"weeks":[43],"and":[44],"can":[45],"improve":[46],"adherence":[47],"due":[48],"infrequent":[50],"parenteral":[51],"administration.":[52],"Here,":[53],"we":[54],"evaluated":[55],"a":[56],"new":[57],"long-acting":[58],"formulation":[59],"raltegravir":[61],"for":[62],"prevention":[63],"vaginal":[65],"transmission.":[67]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2022-10-01T00:00:00"}